RECURRENT OVARIAN CANCER
Clinical trials for RECURRENT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to control recurrent ovarian cancer
Disease control Not yet recruitingThis study tests a new drug called iparomlimab/tuvonralimab (QL1706) combined with standard chemotherapy followed by olaparib in women with platinum-sensitive recurrent ovarian cancer. The goal is to see if this combination can help control the cancer and delay its return. About …
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 11:39 UTC
-
New therapy aims to ease trauma in ovarian cancer patients
Symptom relief Not yet recruitingThis study tests a therapy called CALM-TF to see if it can reduce traumatic stress in women with advanced ovarian cancer. About 300 women, either newly diagnosed or with a recurrence, will receive either CALM-TF sessions plus usual care or just usual care. Researchers will measur…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 26, 2026 10:35 UTC